Dobler, US
Alfred Dobler, Brookfield, CT US
Patent application number | Description | Published |
---|---|---|
20100077676 | ARCHITECTURAL PANEL HANGER - The device to hang an architectural panel on a wall preferably comprises a support structure having first and second surfaces and a circumferential surface therebetween, a hole between the first and second surfaces, and a screw having a head, shaft and plurality of threads about the shaft. The screw is located in the hole and connected to the support structure such that the head is at or below the first surface of the support structure and the shaft is perpendicular thereto. The device can be driven into a wall and will support an architectural panel locatable thereon. Specifically, a panel clip, attached to the back of the architectural panel, can be placed on the support structure and the device will support the panel placed thereon. The circumferential surface of the support structure preferably includes a bevel to facilitate the placement of the panel clip onto the support structure. | 04-01-2010 |
Darin Dobler, Aliso Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20110165675 | CAPPING BIOPROSTHETIC TISSUE TO REDUCE CALCIFICATION - A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization. | 07-07-2011 |
Darin Dobler, Oxnard, CA US
Patent application number | Description | Published |
---|---|---|
20080302372 | METHODS FOR PRE-STRESSING AND CAPPING BIOPROSTHETIC TISSUE - A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification is disclosed. The method includes preconditioning, pre-stressing, or pre-damaging fixed bioprosthetic tissue in a manner that mimics the damage associated with post-implant use, while, and/or subsequently applying a calcification mitigant such as a capping agent or a linking agent to the damaged tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the damage process (service stress) and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. The linking agent will act as an elastic reinforcement or shock-absorbing spring element in the tissue structure at the site of damage from the pre-stressing. In one method, tissue leaflets in assembled bioprosthetic heart valves are preconditioned by simulating actual flow conditions for a predetermined number of cycles, during or after which the valve is exposed to the capping agent. | 12-11-2008 |
Darin P. Dobler, Aliso Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20130134064 | CAPPING BIOPROSTHETIC TISSUE TO REDUCE CALCIFICATION - A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization. | 05-30-2013 |
20140200659 | CAPPING BIOPROSTHETIC TISSUE TO REDUCE CALCIFICATION - A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization. | 07-17-2014 |
20150238659 | BIOPROSTHETIC TISSUE WITH REDUCED CALCIFICATION - A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization. | 08-27-2015 |
20150314042 | BIOPROSTHETIC TISSUE HAVING A REDUCED PROPENSITY FOR IN VIVO CALCIFICATION - A bioprosthetic tissue having a reduced propensity to calcify in vivo, the bioprosthetic tissue. The bioprosthetic tissue comprises an aldehyde cross-linked and stressed bioprosthetic tissue comprising exposed calcium, phosphate or immunogenic binding sites that have been reacted with a calcification mitigant. The bioprosthetic tissue has a reduced propensity to calcify in vivo as compared to aldehyde cross-linked bioprosthetic tissue that has not been stressed and reacted with the calcification mitigant. | 11-05-2015 |
Jeremy T. Dobler, Fort Wayne, IN US
Patent application number | Description | Published |
---|---|---|
20130107263 | REMOTE ABSORPTION SPECTROSCOPY BY CODED TRANSMISSION | 05-02-2013 |
Karl J. Dobler, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20150201516 | DEMARCATION DEVICE - A demarcation device is disclosed. The demarcation device mounts on top of a cable tray. When mounted on the to of a cable tray the demarcation device is above a length of the cable tray and the bottom edge of the demarcation device is parallel with a top edge of the cable tray and a cable path in the cable tray remains un-obstructed. | 07-16-2015 |
Kendall Lee Dobler, Loveland, OH US
Patent application number | Description | Published |
---|---|---|
20090192344 | SURGICAL DEVICES FOR MANIPULATING TISSUE - A surgical kit can be used to manipulate tissue within the body of a patient to create a working space within the body to allow a surgeon to easily access and work within the body using various surgical instruments. A surgical kit can include an implant comprised of a magnetic material which can be engaged with tissue within the body. The kit can further include a surgical instrument having a magnet which can be used to manipulate the implant and tissue engaged therewith. A surgical kit can include an anchor and a hanger configured to engage tissue at different locations within the body and a connection member engaged with the anchor and the hanger such that the connection member can be pulled to move the anchor toward the hanger. A surgical instrument which utilizes a vacuum provided to one or more movable members can also be used to manipulate tissue. | 07-30-2009 |
Markus Dobler, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20080280766 | Pyridopyrazines for Combating Phytopathogenic Fungi - The compounds of the general formula (I) wherein R, R | 11-13-2008 |
20080287472 | Fungicides - Fungicidal compositions comprising derivatives of pyridopyrimidines having the general formula (1): | 11-20-2008 |
20080318962 | Fungicides Based on Nitrogen-Containing Heterocycles - The compound of the general formula (I), wherein W, X, Y, Z, R, R | 12-25-2008 |
20090069333 | FUNGICIDES - This invention relates to novel derivatives of pyridopyrazines and pyridopyridazines, to processes for preparing them, to intermediate chemicals used in their manufacture, to compositions containing them and to methods of using them to combat fungi, especially fungal infections of plants. The fungicidal compounds have the general formula (1) wherein R, R | 03-12-2009 |
Markus Rolf Dobler, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20080255149 | Carboxyamine Compounds and Methods of Use Thereof - The invention relates to the use of carboxyamine compounds and salts thereof in the treatment of HDAC dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases. | 10-16-2008 |
20100120872 | ORGANIC COMPOUNDS AND THEIR USES - The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases. | 05-13-2010 |
20120142685 | ORGANIC COMPOUNDS - The present invention provides a compound formula I: (formula I) said compound is inhibitor of selective subset of kinases belonging to the AGC or calmodulin kinase family, such as for example MARK1/2/3, PKD-1/2/3, PKN-1/2, CDK-9, CaMKII, ROCK-I/II, inhibitors of histone deacetylase (HDAC) phosphorylation, or inhibitors of other kinases. Finally, the present invention also provides a pharmaceutical composition. | 06-07-2012 |
Neil Dobler, Aloha, OR US
Patent application number | Description | Published |
---|---|---|
20150127983 | TEST, VALIDATION, AND DEBUG ARCHITECTURE - An apparatus and method is described herein for providing a test, validation, and debug architecture. At a target or base level, hardware (Design for Test or DFx) are designed into and integrated with silicon parts. A controller may provide abstracted access to such hooks, such as through an abstraction layer that abstracts low level details of the hardware DFx. In addition, the abstraction layer through an interface, such as APIs, provides services, routines, and data structures to higher-level software/presentation layers, which are able to collect test data for validation and debug of a unit/platform under test. Moreover, the architecture potentially provides tiered (multiple levels of) secure access to the test architecture. Additionally, physical access to the test architecture for a platform may be simplified through use of a unified, bi-directional test access port, while also potentially allowing remote access to perform remote test and de-bug of a part/platform under test. In essence, a complete test architecture stack is described herein for test, validation, and debug of electronic parts, devices, and platforms. | 05-07-2015 |
Per Dobler, Huntington, NY US
Patent application number | Description | Published |
---|---|---|
20160133166 | Removable fragrance sampler - A removable fragrance sampler is disclosed in which the sampler comprises a bottom ply having an upper surface and a lower surface with the lower surface having a layer of re-positionable pressure sensitive adhesive and a top ply having a sample material therein, the top ply being attached to the upper surface of the bottom ply, and the bottom ply being larger than the top ply. | 05-12-2016 |
Sven Dobler, Farmingdale, NY US
Patent application number | Description | Published |
---|---|---|
20110000873 | Fragrance slurry pad - The fragrance slurry pad receives a fragrance in slurry and prints the slurry into a recognizable logo, brand, or word upon a strip. To enhance the marketing impact of fragrance strip advertising and to differentiate among marketers without increase in cost, the present invention is fragrance slurry deposition pads that support and reinforce a marketing message. The preferred embodiment has a brand name, logo, or message etched into a flexographic print pad. The print pad applies the slurry to a strip located beneath a flap. Upon opening the flap, the fragrance slurry appears in a discernible pattern and visible message. | 01-06-2011 |
Tamra Dobler, Fruitland, ID US
Patent application number | Description | Published |
---|---|---|
20140000425 | CUTTER BLADE AND METHOD MAKING AND USING THE SAME | 01-02-2014 |
Tamra Jo Dobler, Fruitland, ID US
Patent application number | Description | Published |
---|---|---|
20150086703 | BAKED FRY PROCESS AND PRODUCT - A method of making a baked, non-fried, frozen potato product, suitable for final bake processing, which has at least the flavor, exterior crispness, and interior texture of a par-fried product, with lower fat content, without par-flying. The process, among other things, combines warm oil deluge and impingement oven baking. | 03-26-2015 |